Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Trebst

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Current Pharmaceutical Design|February 4, 2006
Promotion of remyelination by immunoglobulins: implications for the treatment of multiple sclerosisC Trebst, M Stangel
Fortschritte Der Neurologie-Psychiatrie|July 30, 2005
[Cannabinoids in multiple sclerosis -- therapeutically reasonable?]C Trebst, M Stangel
Der Nervenarzt|September 15, 2018
[Neuroimmunology and rheumatology: overlap and differential diagnoses]C Trebst, T Kümpfel
The Journal of Experimental Medicine|May 17, 2000
Surprising pleiotropy of nerve growth factor in the treatment of experimental autoimmune encephalomyelitisR M Ransohoff, C Trebst
Archives of Neurology|December 26, 2001
Investigating chemokines and chemokine receptors in patients with multiple sclerosis: opportunities and challengesC Trebst, R M Ransohoff
Der Nervenarzt|September 15, 2005
[Concepts of lesion development in multiple sclerosis. Current approaches and clinical-therapeutic implications ]C Trebst, H Wiendl, M Stangel
Der Nervenarzt|October 11, 2003
[Chemokine--possible new options for the treatment of multiple sclerosis]C Trebst, R M Ransohoff, A Windhagen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 10, 2008
CCR5 expression on macrophages/microglia is associated with early remyelination in multiple sclerosis lesionsC Trebst, F König, Rm Ransohoff, et al.
European Journal of Neurology|November 23, 2006
Expression of chemokine receptors on peripheral blood mononuclear cells of patients with immune-mediated neuropathies treated with intravenous immunoglobulinsC Trebst, K Brunhorn, M Lindner, et al.
Clinical and Experimental Immunology|November 17, 2004
Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosisS Marckmann, E Wiesemann, R Hilse, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Current Pharmaceutical Design|February 4, 2006
Promotion of remyelination by immunoglobulins: implications for the treatment of multiple sclerosisC Trebst, M Stangel
Fortschritte Der Neurologie-Psychiatrie|July 30, 2005
[Cannabinoids in multiple sclerosis -- therapeutically reasonable?]C Trebst, M Stangel
Der Nervenarzt|September 15, 2018
[Neuroimmunology and rheumatology: overlap and differential diagnoses]C Trebst, T Kümpfel
The Journal of Experimental Medicine|May 17, 2000
Surprising pleiotropy of nerve growth factor in the treatment of experimental autoimmune encephalomyelitisR M Ransohoff, C Trebst
Archives of Neurology|December 26, 2001
Investigating chemokines and chemokine receptors in patients with multiple sclerosis: opportunities and challengesC Trebst, R M Ransohoff
Der Nervenarzt|September 15, 2005
[Concepts of lesion development in multiple sclerosis. Current approaches and clinical-therapeutic implications ]C Trebst, H Wiendl, M Stangel
Der Nervenarzt|October 11, 2003
[Chemokine--possible new options for the treatment of multiple sclerosis]C Trebst, R M Ransohoff, A Windhagen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 10, 2008
CCR5 expression on macrophages/microglia is associated with early remyelination in multiple sclerosis lesionsC Trebst, F König, Rm Ransohoff, et al.
European Journal of Neurology|November 23, 2006
Expression of chemokine receptors on peripheral blood mononuclear cells of patients with immune-mediated neuropathies treated with intravenous immunoglobulinsC Trebst, K Brunhorn, M Lindner, et al.
Clinical and Experimental Immunology|November 17, 2004
Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosisS Marckmann, E Wiesemann, R Hilse, et al.
Pageof 3